Floatz logo

Vesanoid

Oligometastatic Disease

Gustave Roussy, Cancer Campus, Grand ParisPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Oligometastatic Disease cohort.

Asset / SponsorPhaseRating
Eovist
University of Colorado, Denver
Phase 4B
GADOBENATE DIMEGLUMINE
University of Colorado, Denver
Phase 4B
FLUOROURACILUM
UMC Utrecht
Phase 2CCC
Eloxatin
University of Cologne
Phase 2CCC
Tislelizumab
Peking University Cancer Hospital & Institute
Phase 2CCC

View all 20 →

Same molecule, other indications

Vesanoid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
70 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →